Consensus Stride, Inc.

Equities

LRN

US86333M1080

Market Closed - Nyse 04:00:02 2024-04-23 pm EDT 5-day change 1st Jan Change
58.2 USD +0.17% Intraday chart for Stride, Inc. +0.38% -1.97%

Evolution of the average Target Price on Stride, Inc.

Price target over the last 5 years

History of analyst recommendation changes

174c8e2d2d74ccbe32e4392381e1c.PGHxtZp9p8-EnU1hGW0mfU2H7auL1mYRU9CNlY96TRg.DwiG1PMJ5Pzs1R8kSyVACHzWv_zblwh6GarK7cENPktbArzMrjbXjub4Ig~2b9a4e3222f90e6a0d5b8149906b2a2e
BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT
BMO Capital Raises Price Target on Stride to $57 From $50, Maintains Outperform Rating MT
Barrington Raises Price Target on Stride to $60 From $50, After Q1/24 Earnings Top Estimates, Maintains Outperform Rating MT
Morgan Stanley Adjusts Price Target on Stride to $57 From $52, Keeps Equalweight Rating MT
BMO Capital Adjusts Price Target on Stride to $50 From $49, Maintains Outperform Rating MT
Morgan Stanley Adjusts Price Target on Stride to $52 From $50, Keeps Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Stride to $50 From $46, Maintains Equal-Weight Rating MT
Morgan Stanley Downgrades Stride to Equal Weight From Overweight, $46 Price Target MT
ANALYST RECOMMENDATIONS : Admiral, Alaska Air, KeyCorp, SVB Financial, United Airlines... Our Logo
BMO Capital Raises Stride's Price Target to $48 From $47, Maintains Outperform Rating MT
Morgan Stanley Adjusts Price Target on Stride to $46 From $41, Maintains Overweight Rating MT
Morgan Stanley Cuts Price Target on Stride to $41 From $43, Keeps Overweight Rating MT
BMO Capital Trims Stride's Price Target to $50 From $52, Maintains Outperform Rating MT
Morgan Stanley Adjusts Stride Price Target to $43 From $47, Maintains Overweight Rating MT
Morgan Stanley Adjusts Stride's Price Target to $47 from $45, Maintains Overweight Rating MT
Morgan Stanley Upgrades Stride to Overweight From Equalweight, Maintains $45 Price Target MT
Morgan Stanley Upgrades Stride to Overweight From Equalweight, Maintains $45 Price Target MT
Morgan Stanley Raises Stride's Price Target to $45 From $42, Maintains Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Stride to $42 From $39, Maintains Equalweight Rating MT
Morgan Stanley Raises Stride's Price Target to $39 From $36, Maintains Equalweight Rating MT
Morgan Stanley Adjusts Stride Price Target to $36 From $35, Maintains Equal Weight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
58.1 USD
Average target price
71.75 USD
Spread / Average Target
+23.49%
High Price Target
75 USD
Spread / Highest target
+29.09%
Low Price Target
65 USD
Spread / Lowest Target
+11.88%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Stride, Inc.

BMO Capital
Barrington Research
Morgan Stanley
Citigroup
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. LRN Stock
  4. Consensus Stride, Inc.